journal article·2023-06Open access

Fabrication of a composite 3D-printed titanium alloy combined with controlled in situ drug release to prevent osteosarcoma recurrence

Daoyang Fan, Chaoqi Zhang, Hufei Wang, Qingguang Wei, Hong Cai, Feng Wei, Zhilei Bian, Weifeng Liu, Xing Wang, Zhongjun Liu

Abstract

Osteosarcoma is a malignant bone tumor occurring in adolescents. Surgery combined with adjuvant or neoadjuvant chemotherapy is the standard treatment. However, systemic chemotherapy is associated with serious side effects and a high risk of postoperative tumor recurrence, leading to a high amputation rate and mortality in cancer patients. Implant materials that can simultaneously repair large bone defects and prevent osteosarcoma recurrence are in urgent need. Herein, an intelligent system comprising 3D-printed titanium scaffold (TS) and pH-responsive PEGylated paclitaxel prodrugs was fabricated for bone defect reconstruction and recurrence prevention following osteosarcoma surgery. The drug-loaded implants exhibited excellent stability and biocompatibility for supporting the activity of bone stem cells under normal body fluid conditions and the rapid release of drugs in response to faintly acidic environments. An in vitro study demonstrated that five human osteosarcoma cell lines could be efficiently eradicated by paclitaxel released in an acidic microenvironment. Using mice models, we demonstrated that the drug-loaded TS can enable a pH-responsive treatment of postoperative tumors and effectively prevent osteosarcoma recurrence. Therefore, local implantation of this composite scaffold may be a promising topical therapeutic method to prevent osteosarcoma recurrence.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics · Sarcoma Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (58)

Show source-provided references
1. Advancing therapy for osteosarcoma10.1038/s41571-021-00519-8 ↗
2. New horizons in the treatment of osteosarcoma10.1056/NEJMra2103423 ↗
3. Bone microenvironment and osteosarcoma metastasis
4. Current and future therapeutic approaches for osteosarcoma10.1080/14737140.2018.1413939 ↗
5. Survival analysis of osteosarcoma patients: a 15-year experience
6. Three-dimensional-printed individualized porous implants: a new "implant-bone" interface fusion concept for large bone defect treatment
7. Impact of a desmoplastic tumor microenvironment for colon cancer drug sensitivity: a study with 3D chimeric tumor spheroids10.1021/acsami.1c18249 ↗
8. Adjustable and versatile 3D tumor spheroid culture platform with interfacial elastomeric wells10.1021/acsami.9b21471 ↗
9. 3D-Printed multifunctional polyetheretherketone bone scaffold for multimodal treatment of osteosarcoma and osteomyelitis10.1021/acsami.1c10898 ↗
10. Progressive 3D printing technology and its application in medical materials10.3389/fphar.2020.00122 ↗
11. 3D printing in spine surgery10.1007/978-981-13-1396-7_27 ↗
12. Comparison of 3D-printed porous tantalum and titanium scaffolds on osteointegration and osteogenesis10.1016/j.msec.2019.109908 ↗
13. Reconstruction of the upper cervical spine using a personalized 3D-printed vertebral body in an adolescent with ewing sarcoma10.1097/BRS.0000000000001179 ↗
14. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial10.1016/S1470-2045(20)30446-0 ↗
15. Osteosarcoma, chondrosarcoma, and chordoma10.1200/JCO.2017.75.1743 ↗
16. Paclitaxel's mechanistic and clinical effects on breast cancer10.3390/biom9120789 ↗
17. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence10.1038/nnano.2017.54 ↗
18. Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical Trial10.1001/jamaoncol.2019.0270 ↗
19. The battle of "nano" paclitaxel10.1016/j.addr.2017.02.003 ↗
20. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy10.1021/acs.nanolett.7b05263 ↗
21. Aptamer-functionalized micro- and nanocarriers for controlled release10.1021/acsami.0c17121 ↗
22. Aptamer-targeted photodynamic platforms for tumor therapy10.1021/acsami.1c06818 ↗
23. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials10.1016/j.biomaterials.2021.120955 ↗
24. Targeted prodrug-based self-assembled nanoparticles for cancer therapy10.2147/IJN.S247443 ↗
25. Stimuli-responsive prodrug-based cancer nanomedicine10.1016/j.ebiom.2020.102821 ↗
26. Lipids in the tumor microenvironment: from cancer progression to treatment10.1016/j.plipres.2020.101055 ↗
27. Low glycaemic diets alter lipid metabolism to influence tumour growth10.1038/s41586-021-04049-2 ↗
28. One-step preparation of pH-responsive polymeric nanogels as intelligent drug delivery systems for tumor therapy10.1021/acs.biomac.8b00195 ↗
29. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release10.1002/anie.201908997 ↗
30. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery10.1016/j.msec.2017.08.063 ↗
31. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy10.1080/10717544.2018.1451935 ↗
32. Glutathione-responsive prodrug conjugates for image-guided combination in cancer therapy10.1016/j.ejmech.2021.113746 ↗
33. A polydopamine-assisted strontium-substituted apatite coating for titanium promotes osteogenesis and angiogenesis via FAK/MAPK and PI3K/AKT signaling pathways10.1016/j.msec.2021.112482 ↗
34. Polydopamine-assisted immobilization of silk fibroin and its derived peptide on chemically oxidized titanium to enhance biological activity in vitro10.1016/j.ijbiomac.2021.06.160 ↗
35. Characterization and biosafety evaluation of hemoglobin-based oxygen carriers coated with polydopamine10.1166/jbn.2020.2964 ↗
36. Polydopamine: surface coating, molecular imprinting, and electrochemistry-successful applications and future perspectives in analysis10.1007/s00216-019-01665-w ↗
37. Polydopamine coating enhances mucopenetration and cell uptake of nanoparticles10.1021/acsami.8b18107 ↗
38. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review10.1093/bja/aex229 ↗
39. Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer10.1016/j.dnarep.2021.103113 ↗
40. Confocal imaging protocols for live/dead staining in three-dimensional carriers10.1007/978-1-61779-108-6_14 ↗
41. Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer10.1080/10717544.2017.1321060 ↗
42. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line10.1159/000305257 ↗
43. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance10.1111/ajco.13449 ↗
44. Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: roles of depolymerizing kinesins and severing proteins10.1080/15384047.2019.1638678 ↗
45. Microtubules and resistance to tubulin-binding agents10.1038/nrc2803 ↗
46. Photoswitchable paclitaxel-based microtubule stabilisers allow optical control over the microtubule cytoskeleton10.1038/s41467-020-18389-6 ↗
47. Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy10.1007/s00280-017-3398-2 ↗
48. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: in vivo murine model10.1080/10717544.2021.1923863 ↗
49. Establishment of a patient-derived orthotopic osteosarcoma mouse model10.1186/s12967-015-0497-x ↗
50. Animal models in osteosarcoma10.3389/fonc.2014.00189 ↗
51. Genome-informed targeted therapy for osteosarcoma10.1158/2159-8290.CD-17-1152 ↗
52. A novel procedure for orthotopic tibia implantation for establishment of a more clinical osteosarcoma PDOX mouse model10.21873/invivo.12237 ↗
53. Cell death and survival assays10.1007/978-1-4939-7477-1_9 ↗
54. Do tunel and other apoptosis assays detect cell death in preclinical studies?10.3390/ijms21239090 ↗
55. 3D printed titanium scaffolds with homogeneous diamond-like structures mimicking that of the osteocyte microenvironment and its bone regeneration study
56. Improved osseointegration with rhBMP-2 intraoperatively loaded in a specifically designed 3D-printed porous Ti6Al4V vertebral implant10.1039/C9BM01655D ↗
57. The contribution of pore size and porosity of 3D printed porous titanium scaffolds to osteogenesis
58. Transplantation of human meningioma stem cells loaded on a self-assembling peptide nanoscaffold containing IKVAV improves traumatic brain injury in rats10.1016/j.actbio.2019.05.010 ↗